FORWARD PHARMA A/S-ADR (FWP) Stock Price, Quote, News and Overview
NASDAQ:FWP - Nasdaq - US34986J2042 - ADR - Currency: USD
FWP Quote, Performance and Key Statistics
1.95
+0.14 (+7.73%)
The current stock price of FWP is 1.95 USD. In the past month the price decreased by -35%. In the past year, price decreased by -67.34%.
FWP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.08 | 328.52B | ||
| AMGN | AMGEN INC | 13.29 | 148.31B | ||
| GILD | GILEAD SCIENCES INC | 13.72 | 132.17B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 113.28B | ||
| REGN | REGENERON PHARMACEUTICALS | 13.46 | 64.41B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 37.97B | ||
| ARGX | ARGENX SE - ADR | 98.48 | 35.30B | ||
| ONC | BEIGENE LTD-ADR | 5.8 | 25.15B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.51B | ||
| NTRA | NATERA INC | N/A | 20.84B | ||
| BIIB | BIOGEN INC | 8.18 | 18.97B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.83B |
Related stock screener links
About FWP
Company Profile
Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. The firm granted to Biogen an irrevocable license to all of its IP through the License Agreement and received from Biogen a non-refundable cash fee of $1.25 billion in February 2017, with the return of EUR 917.7 million to shareholders through a capital reduction in September 2017. The firm has the opportunity to receive royalties from Biogen on Biogen’s net sales of Tecfidera or other DMF products for multiple sclerosis outside the U.S., dependent on, among other things, a favorable outcome in Europe with respect to the 355 Patent Opposition Proceeding, including any appeal thereto.
Company Info
FORWARD PHARMA A/S-ADR
Oestergade 24A, 1, Copenhagen K
COPENHAGEN 1100 DK
CEO: Claus Bo Svendsen
Employees: 4
Phone: 4533444242.0
FORWARD PHARMA A/S-ADR / FWP FAQ
What is the stock price of FORWARD PHARMA A/S-ADR today?
The current stock price of FWP is 1.95 USD. The price increased by 7.73% in the last trading session.
What is the ticker symbol for FORWARD PHARMA A/S-ADR stock?
The exchange symbol of FORWARD PHARMA A/S-ADR is FWP and it is listed on the Nasdaq exchange.
On which exchange is FWP stock listed?
FWP stock is listed on the Nasdaq exchange.
What is FORWARD PHARMA A/S-ADR worth?
FORWARD PHARMA A/S-ADR (FWP) has a market capitalization of 191.62M USD. This makes FWP a Micro Cap stock.
How many employees does FORWARD PHARMA A/S-ADR have?
FORWARD PHARMA A/S-ADR (FWP) currently has 4 employees.
What are the support and resistance levels for FORWARD PHARMA A/S-ADR (FWP) stock?
FORWARD PHARMA A/S-ADR (FWP) has a resistance level at 2.56. Check the full technical report for a detailed analysis of FWP support and resistance levels.
Should I buy FORWARD PHARMA A/S-ADR (FWP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FWP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FWP, evaluating the profitability, health, valuation and growth aspects
- FORWARD PHARMA A/S-ADR (FWP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- FORWARD PHARMA A/S-ADR (FWP) Sales and EPS estimates to see what analysts future expectations are.
- FORWARD PHARMA A/S-ADR (FWP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- FORWARD PHARMA A/S-ADR (FWP) Insider and Institutional Ownership to learn about the owners and their transactions.
- FORWARD PHARMA A/S-ADR (FWP) Stock Chart to make your own analysis
- FORWARD PHARMA A/S-ADR (FWP) Latest news and press-releases to stay up to date.
Does FORWARD PHARMA A/S-ADR (FWP) stock pay dividends?
FWP does not pay a dividend.
What is the Price/Earnings (PE) ratio of FORWARD PHARMA A/S-ADR (FWP)?
FORWARD PHARMA A/S-ADR (FWP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
FWP Technical Analysis
FWP Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to FWP. While FWP has a great health rating, there are worries on its profitability.
FWP Financial Highlights
Over the last trailing twelve months FWP reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 71.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
FWP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 45% to FWP. The Buy consensus is the average rating of analysts ratings from 8 analysts.